2405-6308

Clinical and Translational Radiation Oncology

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 1213 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact1213 DOIs
2

Attach ORCID iDs across 594 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact594 DOIs
3

Deposit reference lists for 12 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact12 DOIs

DOIs for this ISSN

Showing the top 5 of 1213 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Adaptive radiotherapy: The Elekta Unity MR-linac concept (10.1016/j.ctro.2019.04.001)
Abstract ORCID
123.12 289
2 Technical design and concept of a 0.35 T MR-Linac (10.1016/j.ctro.2019.04.007)
Abstract ORCID
115.48 203
3 COVID-19: Global radiation oncology’s targeted response for… (10.1016/j.ctro.2020.03.009)
Abstract ORCID
101.67 107
4 Treatment de-escalation for HPV-driven oropharyngeal cancer:… (10.1016/j.ctro.2017.10.005)
Abstract ORCID
100.00 99
5 Infrastructure and distributed learning methodology for priv… (10.1016/j.ctro.2016.12.004)
Abstract ORCID
93.75 74
6 Relative biological effectiveness in proton beam therapy – C… (10.1016/j.ctro.2018.01.006)
Abstract ORCID
91.63 67
7 4D-MRI driven MR-guided online adaptive radiotherapy for abd… (10.1016/j.ctro.2020.05.002)
Abstract ORCID
89.62 61
8 Automatic treatment planning improves the clinical quality o… (10.1016/j.ctro.2016.08.001)
Abstract ORCID
89.27 60
9 The technical design and concept of a PET/CT linac for biolo… (10.1016/j.ctro.2021.04.003)
Abstract ORCID
87.41 55
10 A review of the role of MRI in diagnosis and treatment of ea… (10.1016/j.ctro.2020.06.002)
Abstract ORCID
86.62 53
11 PATRIOT: A phase I study to assess the tolerability, safety… (10.1016/j.ctro.2018.06.001)
Abstract ORCID
83.14 45
12 The tumor microenvironment and radiotherapy response; a cent… (10.1016/j.ctro.2020.04.001)
Abstract ORCID
83.14 45
13 Potentials and challenges of diffusion-weighted magnetic res… (10.1016/j.ctro.2018.09.002)
Abstract ORCID
82.66 44
14 Lattice Radiation Therapy in clinical practice: A systematic… (10.1016/j.ctro.2022.100569)
Abstract ORCID
80.10 39
15 The rationale for MR-only treatment planning for external ra… (10.1016/j.ctro.2019.03.005)
Abstract ORCID
79.55 38
16 Daily adaptive radiotherapy for patients with prostate cance… (10.1016/j.ctro.2020.04.011)
Abstract ORCID
78.99 37
17 NBTXR3, a first-in-class radioenhancer for pancreatic ductal… (10.1016/j.ctro.2021.12.012)
Abstract ORCID
78.41 36
18 Time to surgery and pathologic complete response after neoad… (10.1016/j.ctro.2017.04.004)
Abstract ORCID
76.57 33
19 Improved outcome of treating locally advanced lung cancer wi… (10.1016/j.ctro.2018.01.003)
Abstract ORCID
76.57 33
20 Low dose lung radiotherapy for COVID-19 pneumonia. The ratio… (10.1016/j.ctro.2020.04.006)
Abstract ORCID
76.57 33
21 Prostate cancer – Advantages and disadvantages of MR-guided… (10.1016/j.ctro.2019.03.006)
Abstract ORCID
75.93 32
22 Cardiac death after breast radiotherapy and the QUANTEC card… (10.1016/j.ctro.2019.08.001)
Abstract ORCID
75.93 32
23 MR-guided radiotherapy in rectal cancer: First clinical expe… (10.1016/j.ctro.2019.04.006)
Abstract ORCID
75.26 31
24 Scalp angiosarcoma treated with linear accelerator-based bor… (10.1016/j.ctro.2022.02.006)
Abstract ORCID
75.26 31
25 Analysis of pseudoprogression after proton or photon therapy… (10.1016/j.ctro.2018.01.002)
Abstract ORCID
73.86 29
26 Radiomic biomarkers of tumor immune biology and immunotherap… (10.1016/j.ctro.2021.03.006)
Abstract ORCID
73.86 29
27 Evaluation of deep learning-based multiparametric MRI oropha… (10.1016/j.ctro.2021.10.003)
Abstract ORCID
73.86 29
28 Telehealth in radiation oncology at the Townsville Cancer Ce… (10.1016/j.ctro.2018.11.005)
Abstract ORCID
72.36 27
29 Prospective quantitative quality assurance and deformation e… (10.1016/j.ctro.2019.04.018)
Abstract ORCID
71.57 26
30 The radiation dose tolerance of the brachial plexus: A syste… (10.1016/j.ctro.2019.06.006)
Abstract ORCID
71.57 26
31 Blood-brain barrier permeability following conventional phot… (10.1016/j.ctro.2022.04.013)
Abstract ORCID
71.57 26
32 Marker-less online MR-guided stereotactic body radiotherapy… (10.1016/j.ctro.2020.11.014)
Abstract ORCID
70.75 25
33 Evaluation of daily online contour adaptation by radiation t… (10.1016/j.ctro.2021.01.002)
Abstract ORCID
70.75 25
34 Estimating survival in patients with gastrointestinal cancer… (10.1016/j.ctro.2019.06.007)
Abstract ORCID
69.90 24
35 CDK 4/6 inhibitors combined with radiotherapy: A review of l… (10.1016/j.ctro.2020.11.010)
Abstract ORCID
69.90 24
36 Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-… (10.1016/j.ctro.2021.11.007)
Abstract ORCID
69.90 24
37 Anemia, leukocytosis and thrombocytosis as prognostic factor… (10.1016/j.ctro.2017.05.001)
Abstract ORCID
69.01 23
38 Neutrophilia as a biomarker for overall survival in newly di… (10.1016/j.ctro.2018.04.002)
Abstract ORCID
69.01 23
39 Comparison of intratumor and local immune response between M… (10.1016/j.ctro.2022.11.005)
Abstract ORCID
69.01 23
40 Beyond checkpoint inhibition – Immunotherapeutical strategie… (10.1016/j.ctro.2016.12.006)
Abstract ORCID
68.09 22
41 NANO-GBM trial of AGuIX nanoparticles with radiotherapy and… (10.1016/j.ctro.2024.100833)
Abstract ORCID
68.09 22
42 Stability analysis of CT radiomic features with respect to s… (10.1016/j.ctro.2019.11.005)
Abstract ORCID
67.12 21
43 Breast cancer radiation therapy: A bibliometric analysis of… (10.1016/j.ctro.2022.11.015)
Abstract ORCID
67.12 21
44 Stereotactic body radiation therapy is associated with impro… (10.1016/j.ctro.2019.07.007)
Abstract ORCID
66.11 20
45 Profiling of a panel of radioresistant prostate cancer cells… (10.1016/j.ctro.2017.01.005)
Abstract ORCID
65.05 19
46 Do protons and X-rays induce cell-killing in human periphera… (10.1016/j.ctro.2018.01.004)
Abstract ORCID
65.05 19
47 Is there a role for stereotactic radiotherapy in the treatme… (10.1016/j.ctro.2019.04.012)
Abstract ORCID
65.05 19
48 Auto-segmentations by convolutional neural network in cervic… (10.1016/j.ctro.2020.09.004)
Abstract ORCID
65.05 19
49 Dose-dependent volume loss in subcortical deep grey matter s… (10.1016/j.ctro.2020.11.005)
Abstract ORCID
65.05 19
50 Spatially fractionated radiotherapy (Lattice SFRT) in the pa… (10.1016/j.ctro.2024.100830)
Abstract ORCID
65.05 19